Sunil Joshi is the current Vice President, Global Product Team Lead for Oncology Products at Halozyme Therapeutics. With over 20 years of experience in the biopharmaceutical industry, Sunil has strong experience in Oncology drug development and commercialization in US and International markets.
Sunil most recently served as Head of New Product Strategy and Commercial Assessment at Onyx Pharmaceuticals where he co-led the activities to identify, value and acquire new oncology assets for Onyx Pharmaceuticals. In this context Sunil has developed deep insights into strategic planning of development activities and asset valuation processes.
Prior to this role, Sunil spent many years at Bristol-Myers Squibb in various positions of increasing responsibility including US Sales and Marketing, Global Marketing & Operations. As the head of the Oncology business unit for Intercontinental markets, Sunil launched three innovative Oncology medicines in some of the most ACCESS challenged markets gaining unique experience in commercialization of high value Oncologic medicines in price constrained environment. Sunil has played an active role in shaping International commercialization strategies outside of country of origin for numerous Oncology and Hematology products.
Sunil Joshi has a Masters in Science from Bombay University, and a MBA from University of Akron, United States.